Aflac Incorporated

Equities

AFL

US0010551028

Life & Health Insurance

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
85.86 USD +0.28% Intraday chart for Aflac Incorporated +0.99% +4.07%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Aflac Insider Sold Shares Worth $423,105, According to a Recent SEC Filing MT
Aflac Insider Sold Shares Worth $666,760, According to a Recent SEC Filing MT
Transcript : Aflac Incorporated Presents at Bank of America Securities Financial Services Conference 2024, Feb-21-2024 03:20 PM
Aflac Insider Sold Shares Worth $2,436,696, According to a Recent SEC Filing MT
Aflac Insider Sold Shares Worth $2,577,817, According to a Recent SEC Filing MT
Wells Fargo Adjusts Price Target on Aflac to $83 From $82, Maintains Equalweight Rating MT
Aflac Insider Sold Shares Worth $1,247,282, According to a Recent SEC Filing MT
Aflac Insider Sold Shares Worth $1,391,408, According to a Recent SEC Filing MT
Raymond James Raises Aflac Price Target to $88 From $83, Maintains Outperform Rating MT
Sector Update: Financial Stocks Rise Late Afternoon MT
Sector Update: Financial MT
Top Midday Decliners MT
Stocks in motion: Corteva and Ferrari rise, CH Robinson tumbles Our Logo
Traders Digest Earnings, Data as US Equity Futures Turn Mostly Higher Pre-Bell MT
Transcript : Aflac Incorporated, Q4 2023 Earnings Call, Feb 01, 2024
Aflac Q4 Earnings, Revenue Decline; Shares Drop After Hours MT
Tranche Update on Aflac Incorporated's Equity Buyback Plan announced on August 8, 2017. CI
Earnings Flash (AFL) AFLAC INCORPORATED Posts Q4 EPS $1.25, vs. Street Est of $1.45 MT
Earnings Flash (AFL) AFLAC INCORPORATED Posts Q4 Revenue $3.81B, vs. Street Est of $4.39B MT
Aflac Incorporated Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Aflac Incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Aflac Incorporated Declares First Quarter Dividend, Payable on March 1, 2024 CI
Transcript : Aflac Incorporated, Q4 2023 Pre Recorded Earnings Call, Jan 31, 2024
UBS Ups Price Target on Aflac to $84 From $80, Keeps Neutral Rating MT
Goldman Sachs Adjusts Price Target on Aflac to $75 From $61, Maintains Sell Rating MT
Chart Aflac Incorporated
More charts
Aflac Incorporated is a life insurance group organized around 3 sectors of activity: - sale of health and life insurance products in Japan (57.7% of net sales): including cancer life plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities; - sale of health and life insurance products in the United States (39.5%): including accident/disability plans, cancer expense plans, short-term disability plans, sickness and hospital indemnity plans, hospital intensive care plans, fixed-benefit dental plans, vision care plans, and long-term care plans; - other (2.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
85.86 USD
Average target price
83.08 USD
Spread / Average Target
-3.24%
Consensus